AT156823T - Therapeutic heterocyclic compounds - Google Patents

Therapeutic heterocyclic compounds

Info

Publication number
AT156823T
AT156823T AT91911486T AT91911486T AT156823T AT 156823 T AT156823 T AT 156823T AT 91911486 T AT91911486 T AT 91911486T AT 91911486 T AT91911486 T AT 91911486T AT 156823 T AT156823 T AT 156823T
Authority
AT
Austria
Prior art keywords
heterocyclic compounds
therapeutic heterocyclic
therapeutic
compounds
Prior art date
Application number
AT91911486T
Other languages
German (de)
Inventor
Alan Duncan Robertson
Alan Peter Hill
Robert Charles Glen
Graeme Richard Martin
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to GB909012672A priority Critical patent/GB9012672D0/en
Priority to GB919102182A priority patent/GB9102182D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of AT156823T publication Critical patent/AT156823T/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26297174&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT156823(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
AT91911486T 1990-06-07 1991-06-06 Therapeutic heterocyclic compounds AT156823T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB909012672A GB9012672D0 (en) 1990-06-07 1990-06-07 Therapeutic heterocyclic compounds
GB919102182A GB9102182D0 (en) 1991-02-01 1991-02-01 Therapeutic heterocyclic compounds

Publications (1)

Publication Number Publication Date
AT156823T true AT156823T (en) 1997-08-15

Family

ID=26297174

Family Applications (2)

Application Number Title Priority Date Filing Date
AT91911486T AT156823T (en) 1990-06-07 1991-06-06 Therapeutic heterocyclic compounds
AT94115107T AT204275T (en) 1990-06-07 1991-06-06 Indole derivatives as 5-HT1-like agonists

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT94115107T AT204275T (en) 1990-06-07 1991-06-06 Indole derivatives as 5-HT1-like agonists

Country Status (35)

Country Link
US (3) US5399574A (en)
EP (2) EP0636623B1 (en)
JP (1) JP2738461B2 (en)
KR (1) KR100215627B1 (en)
AT (2) AT156823T (en)
AU (1) AU646871B2 (en)
CA (2) CA2282890C (en)
CZ (1) CZ288351B6 (en)
DE (5) DE69132691T2 (en)
DK (1) DK0486666T3 (en)
EG (1) EG19650A (en)
ES (1) ES2104708T3 (en)
FI (3) FI105686B (en)
GR (1) GR3024828T3 (en)
HK (1) HK1000534A1 (en)
HR (1) HRP940524B1 (en)
HU (2) HU219974B (en)
IE (2) IE20010862A1 (en)
IL (3) IL114690A (en)
LT (1) LT3264B (en)
LU (1) LU90205I2 (en)
LV (1) LV10274B (en)
MC (1) MC2210A1 (en)
MX (1) MX9203421A (en)
NL (1) NL980001I2 (en)
NO (1) NO300634B1 (en)
NZ (1) NZ238424A (en)
PL (1) PL166214B1 (en)
PT (1) PT97888B (en)
RU (1) RU2160736C2 (en)
SA (1) SA672B1 (en)
SI (2) SI9111010B (en)
SK (1) SK281621B6 (en)
WO (1) WO1991018897A1 (en)
YU (1) YU48855B (en)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ283018B6 (en) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Imidazole, triazole and tetrazole derivatives, process of their preparation, their use and pharmaceuticals based thereon
TW263508B (en) * 1991-02-12 1995-11-21 Pfizer
JP2840448B2 (en) * 1991-11-25 1998-12-24 フアイザー・インコーポレイテツド Indole derivatives
GB9201038D0 (en) * 1992-01-16 1992-03-11 Glaxo Group Ltd Chemical compounds
TW288010B (en) * 1992-03-05 1996-10-11 Pfizer
CA2129146A1 (en) * 1992-03-13 1993-09-16 Victor Giulio Matassa Imidazole, triazole and tetrazole derivatives
GB9207396D0 (en) * 1992-04-03 1992-05-13 Merck Sharp & Dohme Therapeutic agents
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
CZ281763B6 (en) * 1992-04-07 1997-01-15 Pfizer Inc. Indole derivatives representing 5-ht1 agonists, pharmaceutical compositions containing thereof, their use and intermediates for their preparation
GB9207930D0 (en) * 1992-04-10 1992-05-27 Pfizer Ltd Indoles
CA2132706C (en) * 1992-04-10 1998-08-04 John Eugene Macor Acylaminoindole derivatives as 5-ht1 agonists
GB9208161D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Indoles
GB9208463D0 (en) * 1992-04-16 1992-06-03 Merck Sharp & Dohme Therapeutic agents
GB9209882D0 (en) * 1992-05-07 1992-06-24 Glaxo Lab Sa Compositions
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
CA2138649A1 (en) * 1992-07-24 1994-02-03 Raymond Baker Imidazole, triazole and tetrazole derivatives
GB9216009D0 (en) * 1992-07-28 1992-09-09 Almirall Lab New indol derivatives
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme 4-substituted 1, 2, 4-triazole derivatives, their preparation and pharmaceutical compositions containing them
ES2056025B1 (en) * 1992-10-08 1995-05-01 Almirall Lab Novel indole derivatives.
TW251284B (en) * 1992-11-02 1995-07-11 Pfizer
GB9226532D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
FR2701026B1 (en) * 1993-02-02 1995-03-31 Adir Novel derivatives of indole, indazole and benzisoxazole, process for their preparation and pharmaceutical compositions containing them.
ES2070087B1 (en) * 1993-08-13 1996-02-16 Pfizer Indole derivatives
CZ59996A3 (en) * 1993-08-31 1996-06-12 Pfizer 5-arylindole derivatives per se and for treating diseases, intermediates for their preparation and pharmaceutical compositions based thereon
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US6423731B2 (en) 1994-01-06 2002-07-23 Zeneca Limited Indole derivatives as prodrugs of 5-HT1-like receptor agonists
GB9401436D0 (en) * 1994-01-26 1994-03-23 Wellcome Found Therapeutic heterocyclic compounds
US5807857A (en) * 1994-05-19 1998-09-15 Merck Sharp & Dohme Ltd. Piperazine, piperidine and tetrahydropyridine derivative of indol-3-alkyl as 5-HT1D-α agonists
WO1995032966A1 (en) * 1994-06-01 1995-12-07 Zeneca Limited Indole derivatives as prodrugs of 5-ht1-like receptor agonists
EP0773942A1 (en) * 1994-07-26 1997-05-21 Pfizer Inc. 4-indole derivatives as serotonin agonists and antagonists
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
WO1996017842A1 (en) * 1994-12-06 1996-06-13 Merck Sharp & Dohme Limited Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists
DE4443892A1 (en) * 1994-12-09 1996-06-13 Bayer Ag 4- (quinolin-2-yl-methoxy) phenyl-acetic acid derivatives
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
JPH11502816A (en) * 1995-03-20 1999-03-09 イーライ・リリー・アンド・カンパニー 5-substituted-3- (1,2,3,6-tetrahydropyridin-4-yl) - and 3- (piperidin-4-yl)-1h-indole: New 5-ht ▲ bottom 1f ▼ agonist
GB9515060D0 (en) * 1995-07-22 1995-09-20 Wellcome Found Therapeutic heterocyclic compounds
GB9515305D0 (en) * 1995-07-26 1995-09-20 Wellcome Found Therapeutic heterocyclic compounds
US6909005B1 (en) * 1995-08-07 2005-06-21 Astrazeneca Uk Limited One post synthesis of 2-oxazolidinone derivatives
GB9516143D0 (en) 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
GB9516145D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
WO1997013512A1 (en) * 1995-10-10 1997-04-17 Eli Lilly And Company N-[2-substituted-3-(2-aminoethyl)-1h-indol-5-yl]-amides: new 5-ht1f agonists
US5998415A (en) * 1995-11-02 1999-12-07 Merck Sharp & Dohme Ltd. Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation, and their use of as selective agonists of 5-HT1 -like receptors
GB9609374D0 (en) * 1996-05-03 1996-07-10 Merck Sharp & Dohme Therapeutic agents
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
AR017200A1 (en) 1997-12-23 2001-08-22 Astrazeneca Ab Inhibitor compounds protein kinase C, pharmaceutically acceptable salts thereof, formulations comprising farmaceuitcas, usode the same and process for the synthesis of such compounds
SE9800835D0 (en) 1998-03-13 1998-03-13 Astra Ab New Compounds
AU4961499A (en) * 1998-06-26 2000-01-17 Eli Lilly And Company 5-HT1f agonists
US6346625B1 (en) * 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
IL163666D0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
US6492406B1 (en) 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
GB9928578D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Pharmaceutical formulations
KR100670092B1 (en) * 1999-12-03 2007-01-17 아스트라제네카 아베 Pharmaceutical Formulations Containing Zolmitriptan
DE60130677T2 (en) * 2000-11-29 2008-07-17 Eli Lilly And Co., Indianapolis 1- (2-m-methanesulfonamidophenylethyl) -4- (m-trifluoromethylphenyl) piperazine and their pharmaceutical acceptable salts and solvates and their use for treatment of incontinence
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7090830B2 (en) * 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20070122353A1 (en) * 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
DE60228294D1 (en) * 2001-06-05 2008-09-25 Ronald Aung-Din Topische migränetherapie
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US7458374B2 (en) * 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
RU2320663C2 (en) 2002-06-21 2008-03-27 Сувен Лайф Сайенсиз Лимитед Novel arylalkylindoles showing affinity to serotonin receptor and useful as drugs, method for their preparing and pharmaceutical compositions containing thereof
WO2004000849A2 (en) 2002-06-21 2003-12-31 Suven Life Sciences Limited Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
ES2204302B2 (en) 2002-08-07 2005-03-01 Laboratorios Vita, S.A. Process for preparing a pharmaceutically active compound.
US20040105818A1 (en) * 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) * 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
AU2003285759B2 (en) 2002-11-28 2010-01-28 Suven Life Sciences Limited N-arylsulfonyl-3-aminoalkoxyindoles
JP4559230B2 (en) 2002-11-28 2010-10-06 スベン ライフ サイエンシズ リミティド New n- arylsulfonyl-3-substituted indoles having affinity for serotonin receptors, processes for their preparation, pharmaceutical compositions containing them
EA009367B1 (en) 2002-12-18 2007-12-28 Сувен Лайф Сайенсиз Лимитед 5-THIA-5-DIOXO-4b AZA INDENO [2,1-a] INDENE DERIVATIVES HAVING SEROTONIN RECEPTOR AFFINITY
CN1729174B (en) * 2002-12-20 2015-10-21 西巴特殊化学品控股有限公司 Amine and intermediates for the synthesis of amine
WO2004063175A1 (en) * 2003-01-13 2004-07-29 Natco Pharma Limited A novel and an improved process for the preparation of (s)-4-(4-aminobenzyl)-2- oxazolidinone
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
US20040192958A1 (en) * 2003-03-25 2004-09-30 Hyatt John Anthony Process for preparing derivatives of 4-halobutyraldehyde
EP1625333A1 (en) 2003-05-21 2006-02-15 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
MY142655A (en) * 2003-06-12 2010-12-15 Euro Celtique Sa Therapeutic agents useful for treating pain
WO2004112723A2 (en) 2003-06-20 2004-12-29 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
BRPI0412808A (en) * 2003-07-24 2006-09-26 Euro Celtique Sa piperidine compounds and pharmaceutical compositions containing them
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
US20070173536A1 (en) * 2004-02-06 2007-07-26 Ciba Specialty Chemicals Holding Inc. Crystalline forms of zolmitriptan
US7540286B2 (en) * 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
CA2576961A1 (en) * 2004-08-12 2006-03-02 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
US20060211751A1 (en) * 2004-11-19 2006-09-21 Reuven Izsak Zolmitriptan crystal forms
US7375219B2 (en) 2005-04-13 2008-05-20 Neuraxon, Inc. Substituted indole compounds having NOS inhibitory activity
AT510836T (en) 2006-01-19 2011-06-15 Matrix Lab Ltd Conversion of an aromatic diazonium salt in an arylhydrazine
WO2007118314A1 (en) * 2006-04-13 2007-10-25 Neuraxon, Inc. 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
WO2008018090A2 (en) * 2006-08-09 2008-02-14 Matrix Laboratories Ltd An improved process for the preparation of zolmitriptan
AU2007310949A1 (en) * 2006-10-19 2008-04-24 Auspex Pharmaceuticals, Inc. Substituted indoles
EP2425819A1 (en) * 2007-02-11 2012-03-07 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
CZ2007158A3 (en) * 2007-02-26 2008-10-22 Zentiva, A. S. Process for preparing zolmitriptan
AR066146A1 (en) 2007-04-27 2009-07-29 Shionogi & Co Trpvi antagonists and uses thereof
EP2091936B1 (en) * 2007-04-27 2013-05-15 Purdue Pharma LP Therapeutic agents useful for treating pain
CN101883766A (en) * 2007-10-03 2010-11-10 基因里克斯(英国)有限公司 Process for the preparation of zolmitriptan, salts and solvates thereof
CA2705833A1 (en) * 2007-11-16 2009-05-22 Subhash C. Annedi 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
CN101910157B (en) 2007-11-16 2014-05-07 纽尔亚商股份有限公司 Indole compounds and methods for treating visceral pain
CA2705422A1 (en) * 2007-11-16 2009-05-22 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for treating visceral pain
EP2282721B1 (en) 2008-05-14 2018-02-14 SK Biopharmaceuticals Co., Ltd. Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant
US8592424B2 (en) 2008-06-30 2013-11-26 Afgin Pharma Llc Topical regional neuro-affective therapy
US20100217013A1 (en) * 2008-12-15 2010-08-26 Wenge Li Enantioselective process for the preparation of zolmitriptan
US20110171141A1 (en) * 2009-06-26 2011-07-14 Kellerman Donald J Administration of dihydroergotamine mesylate particles using a metered dose inhaler
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
US20110038928A1 (en) * 2009-08-12 2011-02-17 Glenmark Generics Ltd Orally disintegrating tablets of zolmitriptan
JP5907975B2 (en) 2010-10-15 2016-04-26 コンテラ ファーマ アンパルトセルスカブContera Pharma Aps The combination of serotonin receptor agonists for the treatment of movement disorders
CN103717594B (en) 2011-06-22 2016-12-14 普渡制药公司 Dihydroxy-substituted group containing an antagonist and the use thereof trpv1
EP2751098B1 (en) 2011-09-02 2017-11-29 Emcure Pharmaceuticals Limited An improved process for preparation of zolmitriptan
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions
AU2016226267A1 (en) 2015-03-02 2017-09-28 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoids
WO2017122161A1 (en) 2016-01-15 2017-07-20 Cadila Healthcare Limited An intranasal composition comprising 5ht1b/1d receptor agonists
WO2017130141A1 (en) 2016-01-27 2017-08-03 Instar Technologies A.S. Oromucosal nanofiber carriers for therapeutic treatment

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB148879A (en) * 1919-02-14 1921-11-10 Emil Vincance Noser Locks for shift levers of automobiles
US3320282A (en) * 1962-10-29 1967-05-16 Pfizer & Co C Process for preparing esters of 2-hydroxy-3-(3-indolyl) alkanoic acids
US3879410A (en) * 1971-02-08 1975-04-22 Messrs Lab Guidotti & C S P A 4-Aryl-4-oxazolin-2-ones exhibiting myotonic and myorelaxing activity
BE795457A (en) * 1972-02-16 1973-08-16 Clin Midy Indole amines, their preparation and their therapeutic application
FR2179582B1 (en) * 1972-04-13 1975-10-10 Synthelabo
US3873559A (en) * 1973-03-30 1975-03-25 Squibb & Sons Inc Heterocyclic carboxamido thiazolinyl indoles
IT995110B (en) * 1973-08-01 1975-11-10 Snam Progetti Process for the production of heterocyclic compounds and products obtained
US4042595A (en) * 1973-08-01 1977-08-16 Snam Progetti S.P.A. Processes for the production of heterocyclic compounds
US3931229A (en) * 1973-08-23 1976-01-06 Warner-Lambert Company 3-Thiomethyl-2[2-(dialkylamino)ethyl]indoles
US4049816A (en) * 1975-03-24 1977-09-20 Beecham Group Limited Antiviral 2-amino-5-[1-(indol-3-yl)alkyl]-2-thiazolin-4-ones
US4062862A (en) * 1975-07-04 1977-12-13 Nippon Chemiphar Co., Ltd. 5-Benzyl-2-oxazolidone derivatives and a process for producing the same
GB1482879A (en) * 1975-07-24 1977-08-17 Nippon Chemiphar Co 5-benzyl-2-oxazolidone derivatives and a process for producing the same
GB1469200A (en) * 1975-11-28 1977-03-30 Warner Lambert Co 3-thiomethyl-2-2-dialkylamino-ethyl-indoles
DE2557341A1 (en) * 1975-12-19 1977-06-30 Hoechst Ag Basically substituted indole derivatives and processes for their preparation
IT1109002B (en) * 1977-09-22 1985-12-16 Menarini Sas Derivatives of 2 oxazolidone and their methods of preparation
US4137404A (en) * 1977-12-20 1979-01-30 Hoffmann-La Roche Inc. Synthesis of tryptophans
US4198501A (en) * 1977-12-20 1980-04-15 Hoffmann-La Roche Inc. Synthesis of tryptophans
JPS6014032B2 (en) * 1978-01-20 1985-04-11 Nippon Chemiphar Co
US4348393A (en) * 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
DE2933636A1 (en) * 1978-08-30 1980-03-20 Sandoz Ag New n-phenylindolinderivate, their production and preparations containing these compounds pharmaceutical
ZA7905239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
US4255432A (en) * 1979-09-06 1981-03-10 Syntex (U.S.A.) Inc. 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof
US4272555A (en) * 1979-09-21 1981-06-09 Monsanto Company Conversion of carbon-containing materials to carbon monoxide
EP0083566A1 (en) * 1980-04-10 1983-07-13 Sandoz Ag Isoxazolyl indoles
JPS574986A (en) * 1980-06-13 1982-01-11 Paamakemu Asia:Kk Preparation of oxazolidine derivative
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4753956A (en) * 1981-01-02 1988-06-28 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4448971A (en) * 1981-01-02 1984-05-15 Pfizer Inc. Hypoglycemic 5-phenyl-substituted oxazolidine-2,4-diones
US4399296A (en) * 1981-01-02 1983-08-16 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4407811A (en) * 1981-01-02 1983-10-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
DK157920C (en) * 1980-08-12 1990-08-06 Glaxo Group Ltd Analogifremgangsmaade for the preparation of indole derivatives
ZA8105541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
JPS57169458A (en) * 1981-04-13 1982-10-19 Paamakemu Asia:Kk Preparation of indole derivative
CH656124A5 (en) * 1982-04-13 1986-06-13 Sandoz Ag 2-substituted-3-indolamine, processes for their preparation and their use.
IT1170387B (en) * 1982-06-07 1987-06-03 Glaxo Group Ltd Heterocyclic compounds, process for preparing them and pharmaceutical compositions containing them
US4803218A (en) * 1982-09-29 1989-02-07 Mcneilab, Inc. 3-aminoalkyl-1H-indole-5-urea and amide derivatives
US4500717A (en) * 1983-03-28 1985-02-19 The Dow Chemical Company Process for preparation of 2-oxazolidinones
US4831153A (en) * 1983-06-27 1989-05-16 The Dow Chemical Company Preparation of N-vinyl-2-oxazolidinone
GB8321813D0 (en) * 1983-08-12 1983-09-14 Vickers Plc Radiation sensitive compounds
DE3333450A1 (en) * 1983-09-16 1985-04-11 Hoechst Ag carbonylmethylene containing trihalomethyl groups, methods for their manufacture and light-sensitive mixture which contains these compounds
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
DE3430284A1 (en) * 1984-08-17 1986-02-27 Troponwerke Gmbh & Co Kg New tryptamine derivatives, a process for their production and their use
NL8503337A (en) * 1984-12-04 1986-07-01 Glaxo Group Ltd Indole derivatives.
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
DE3514696A1 (en) * 1985-04-24 1986-11-06 Bayer Ag N-indolyl-sulfonamides, processes for their production and their use
DE3531658A1 (en) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Heterocyclic-substituted indoles, intermediates, processes for their preparation and pharmaceutical compositions
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
GB8531612D0 (en) * 1985-12-23 1986-02-05 Beecham Wuelfing Gmbh & Co Kg Compounds
SE451840B (en) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optically pure monohydrate of S - (-) - 1-propyl-2 ', 6'-pipecoloxylidide hydrochloride, seen to be Stella and this pharmaceutical preparations for local anesthesia
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8607824D0 (en) * 1986-03-27 1986-04-30 Glaxo Group Ltd Chemical compounds
DE3643957A1 (en) * 1986-12-22 1988-06-30 Bayer Ag Substituted n-methylisoxazolidine
DE3882614T2 (en) * 1987-08-13 1993-11-18 Glaxo Group Ltd Indole derivatives.
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
DE3730777A1 (en) * 1987-09-12 1989-03-23 Basf Ag A process for preparing imidazolidinones and oxazolidinones
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
DE3823299A1 (en) * 1988-07-07 1990-01-11 Schering Ag Substituted phenyl-pyrrolidin-2-one, oxazolidin-2-one and imidazolidin-2-ones, their preparation and use in medicaments
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
AU617871B2 (en) * 1988-09-15 1991-12-05 Pharmacia & Upjohn Company In position 3 substituted-5-beta-amidomethyl-oxazolidin-2- ones
DE3939238A1 (en) * 1989-11-28 1991-05-29 Bayer Ag Heterocyclic-substituted acrylate
DE4013907A1 (en) * 1990-04-26 1991-10-31 Schering Ag Prepn. of 3-alkylamino methyl-indole derivs. from indole deriv.
CZ283018B6 (en) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Imidazole, triazole and tetrazole derivatives, process of their preparation, their use and pharmaceuticals based thereon
US5409941A (en) * 1992-02-03 1995-04-25 Pfizer Inc. 5-heteroyl indole derivatives
GB9104136D0 (en) * 1991-02-27 1991-04-17 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
MX9203421A (en) 1992-07-01
DK0486666T3 (en) 1998-03-30
HU211479A9 (en) 1995-11-28
HRP940524B1 (en) 1998-10-31
ES2104708T3 (en) 1997-10-16
SK281621B6 (en) 2001-05-10
FI20001406A (en) 2000-06-13
FI106262B1 (en)
HK1000534A1 (en) 1998-04-03
EP0636623B1 (en) 2001-08-16
DE69132691T2 (en) 2002-06-20
MC2210A1 (en) 1992-11-26
CZ288351B6 (en) 2001-05-16
US5863935A (en) 1999-01-26
US5399574A (en) 1995-03-21
LV10274B (en) 1995-04-20
AT204275T (en) 2001-09-15
HUT62289A (en) 1993-04-28
EP0486666B1 (en) 1997-08-13
AU646871B2 (en) 1994-03-10
SA672B1 (en) 2006-04-04
NL980001I2 (en) 1998-05-06
FI960155A0 (en) 1996-01-12
YU48855B (en) 2002-06-19
NO300634B1 (en) 1997-06-30
GR3024828T3 (en) 1998-01-30
PL166214B1 (en) 1995-04-28
HRP940524A2 (en) 1996-06-30
DE69132691D1 (en) 2001-09-20
IL98392D0 (en) 1992-07-15
SA05260104A (en) 2005-12-03
LU90205I2 (en) 1998-04-06
FI960155A (en) 1996-01-12
SI9111010A (en) 1997-12-31
SI21560A (en) 2005-02-28
US5466699A (en) 1995-11-14
NZ238424A (en) 1993-12-23
HU9200384D0 (en) 1992-06-29
DE69127260D1 (en) 1997-09-18
FI105686B (en) 2000-09-29
NO920494L (en) 1992-03-30
JPH05502679A (en) 1993-05-13
IL114690D0 (en) 1995-11-27
IE911931A1 (en) 1991-12-18
KR100215627B1 (en) 1999-08-16
LV10274A (en) 1994-10-20
CS172791A3 (en) 1992-02-19
DE69127260T2 (en) 1997-12-04
AU7957091A (en) 1991-12-31
EP0636623A1 (en) 1995-02-01
YU101091A (en) 1994-04-05
WO1991018897A1 (en) 1991-12-12
CA2064815A1 (en) 1991-12-08
PT97888B (en) 1998-12-31
CA2282890A1 (en) 1991-12-08
FI106262B (en) 2000-12-29
LU90205A9 (en)
EP0486666A1 (en) 1992-05-27
HU219974B (en) 2001-10-28
CA2064815C (en) 1999-11-16
FI920503A0 (en) 1992-02-06
LT3264B (en) 1995-05-25
NL980001I1 (en) 1998-03-02
EG19650A (en) 1995-09-30
IE20010862A1 (en) 2003-03-05
IL114690A (en) 1997-02-18
FI960155D0 (en)
RU2160736C2 (en) 2000-12-20
FI920503D0 (en)
FI105686B1 (en)
CA2282890C (en) 2001-07-31
JP2738461B2 (en) 1998-04-08
IL98392A (en) 1996-01-19
LTIP419A (en) 1994-11-25
NO920494D0 (en) 1992-02-06
SI9111010B (en) 2005-02-28
SI21560B (en) 2005-04-30
PT97888A (en) 1992-05-29
DE19775091I2 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
AT150702T (en) Suboberflächebeschriftung
AT281234T (en) Fliessbettchromatographieverfahren
AT146921T (en) Spreizbandkommunikationssystem
AT145201T (en) Dihydro-isoquinolinderivate
DE69117705D1 (en) Organic Bekämpfungsteilchen
FI951004A (en) substituted thiazolidinedione derivatives
AT168101T (en) Arylpyridazinone
DE69115445T2 (en) plaster
DE69132119T2 (en) N- (4-piperidinyl -) - dihydrobenzofuran or dihydro-2H-benzopyran-carboxamide derivatives
DE69133442D1 (en) Growth-promoting drug
AT145974T (en) Sicherheitsschliessvorrichtung
NO882799D0 (en) Heterocyclic compounds.
DE3316932A1 (en) heterocyclic compounds
NO930222L (en) Quinuclidine derivatives
NO943140D0 (en) heterobicyclic compounds
DE69128258D1 (en) Electro-optic connections
DE69132270T2 (en) Implantable glucose-sensor
DE69127970T2 (en) immunosuppressive compounds
NO922147D0 (en) heterocyclic derivatives
DE69233053D1 (en) Steroid-sulfatase inhibitory compounds
DE69232336T2 (en) Nitrogen-containing compounds hydrocyclische
DE69525355T2 (en) 1-acyl-4-aminopiperidine aliphatic compounds
DE69636086D1 (en) Oxygen-containing heterocyclic compounds
DE3774591D1 (en) Heterocyclic compounds.
DE3769049D1 (en) Heterocyclic compounds.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
ESZA Application filed for a certificate of protection (e-series)

Free format text: SZ 72/97, 971222

EEZF Grant for a certificate of protection (e-series)

Free format text: SZ 72/1997, 19971222, EXPIRES:20120307

EELA Cancelled due to lapse of time